ISSN 2394-5125
 

Review Article 


Multi Drug Resistance in Cancer Therapy-An Overview

HARISH KADKOL, VIKAS JAIN, AMIT B PATIL*.

Abstract
Multidrug resistance is a mechanism by which chemotherapeutic drugs develops resistance in cancer treatment. Multidrug resistance (MDR) is the
most essential test to compelling chemotherapeutic efficacy against tumor growth. Improvements in the DNA microarray, proteomics innovation
and the outgrowth of focused treatments convey the new ways to deal with the drug resistance in spite the structures of the new chemotherapy
drugs. The chemotherapeutic drugs develops multi drug resistance as the drug treats the tumor but the cells tends to shows a resistant effect for the
same drug when used again, despite their diverse concoction structure and distinctive mechanism of intracellular activity. The scope of the review
explains us about multi drug resistance, the mechanisms of malignant growth inhibiting drugs and overcoming multidrug-resistance.

Search Criteria: A literature survey was done in Scopus, PubMed, Google Scholar, and Science Direct database for articles for published articles
from 1946 to 2019 on multidrug resistant and its mechanism on cancer

Key words: Multidrug resistance, Cancer, Chemotherapy, Chemo sensitizer


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by HARISH KADKOL
Articles by VIKAS JAIN
Articles by AMIT B PATIL*
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

HARISH KADKOL, VIKAS JAIN, AMIT B PATIL. Multi Drug Resistance in Cancer Therapy-An Overview. JCR. 2019; 6(6): 1-6. doi:10.22159/jcr.2019v6i6.35673


Web Style

HARISH KADKOL, VIKAS JAIN, AMIT B PATIL. Multi Drug Resistance in Cancer Therapy-An Overview. http://www.jcreview.com/?mno=302644831 [Access: April 18, 2021]. doi:10.22159/jcr.2019v6i6.35673


AMA (American Medical Association) Style

HARISH KADKOL, VIKAS JAIN, AMIT B PATIL. Multi Drug Resistance in Cancer Therapy-An Overview. JCR. 2019; 6(6): 1-6. doi:10.22159/jcr.2019v6i6.35673



Vancouver/ICMJE Style

HARISH KADKOL, VIKAS JAIN, AMIT B PATIL. Multi Drug Resistance in Cancer Therapy-An Overview. JCR. (2019), [cited April 18, 2021]; 6(6): 1-6. doi:10.22159/jcr.2019v6i6.35673



Harvard Style

HARISH KADKOL, VIKAS JAIN, AMIT B PATIL (2019) Multi Drug Resistance in Cancer Therapy-An Overview. JCR, 6 (6), 1-6. doi:10.22159/jcr.2019v6i6.35673



Turabian Style

HARISH KADKOL, VIKAS JAIN, AMIT B PATIL. 2019. Multi Drug Resistance in Cancer Therapy-An Overview. Journal of Critical Reviews, 6 (6), 1-6. doi:10.22159/jcr.2019v6i6.35673



Chicago Style

HARISH KADKOL, VIKAS JAIN, AMIT B PATIL. "Multi Drug Resistance in Cancer Therapy-An Overview." Journal of Critical Reviews 6 (2019), 1-6. doi:10.22159/jcr.2019v6i6.35673



MLA (The Modern Language Association) Style

HARISH KADKOL, VIKAS JAIN, AMIT B PATIL. "Multi Drug Resistance in Cancer Therapy-An Overview." Journal of Critical Reviews 6.6 (2019), 1-6. Print. doi:10.22159/jcr.2019v6i6.35673



APA (American Psychological Association) Style

HARISH KADKOL, VIKAS JAIN, AMIT B PATIL (2019) Multi Drug Resistance in Cancer Therapy-An Overview. Journal of Critical Reviews, 6 (6), 1-6. doi:10.22159/jcr.2019v6i6.35673